Evidence map›Paper›PMID 35586534›Full record

ReviewMovement disorders clinical practice2022

Do Patients with Progressive Supranuclear Palsy Have Episodic Memory Impairment? A Systematic Review.

Arthur Cassa Macedo, Luciano Inácio Mariano, Marina Isoni Martins, Clarisse Vasconcelos Friedlaender, Jesus Mística Ventura, João Victor de Faria Rocha, Sarah Teixeira Camargos, Francisco Eduardo Costa Cardoso, Paulo Caramelli, Leonardo Cruz de Souza

Open access · bronzeAbstract readReview
In one paragraph

Review in Movement disorders clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Pathomechanisms of cognitive impairment in progressive supranuclear palsy.Journal of neural transmission (Vienna, Austria : 1996) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Arthur Cassa MacedoGrupo de Neurologia Cognitiva e do Comportamento, Faculdade de Medicina Universidade Federal de Minas Gerais (UFMG) Belo Horizonte MG Brazil.
Luciano Inácio MarianoGrupo de Neurologia Cognitiva e do Comportamento, Faculdade de Medicina Universidade Federal de Minas Gerais (UFMG) Belo Horizonte MG Brazil.
Marina Isoni MartinsPrograma de Pós-Graduação em Neurociências Universidade Federal de Minas Gerais (UFMG) Belo Horizonte MG Brazil.
Clarisse Vasconcelos FriedlaenderGrupo de Neurologia Cognitiva e do Comportamento, Faculdade de Medicina Universidade Federal de Minas Gerais (UFMG) Belo Horizonte MG Brazil.
Jesus Mística VenturaGrupo de Neurologia Cognitiva e do Comportamento, Faculdade de Medicina Universidade Federal de Minas Gerais (UFMG) Belo Horizonte MG Brazil.
João Victor de Faria RochaDepartamento de Psicologia, Faculdade de Filosofia e Ciências Humanas Universidade Federal de Minas Gerais (UFMG) Belo Horizonte MG Brazil.
Sarah Teixeira CamargosPrograma de Pós-Graduação em Neurociências Universidade Federal de Minas Gerais (UFMG) Belo Horizonte MG Brazil.
Francisco Eduardo Costa CardosoPrograma de Pós-Graduação em Neurociências Universidade Federal de Minas Gerais (UFMG) Belo Horizonte MG Brazil.ORCID https://orcid.org/0000-0003-0808-0116
Paulo CaramelliGrupo de Neurologia Cognitiva e do Comportamento, Faculdade de Medicina Universidade Federal de Minas Gerais (UFMG) Belo Horizonte MG Brazil.ORCID https://orcid.org/0000-0002-4786-6990
Leonardo Cruz de SouzaGrupo de Neurologia Cognitiva e do Comportamento, Faculdade de Medicina Universidade Federal de Minas Gerais (UFMG) Belo Horizonte MG Brazil.ORCID https://orcid.org/0000-0001-5027-9722
Universidade Federal de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Progressive supranuclear palsy (PSP) is the most common atypical parkinsonism and has executive dysfunction as a core feature. The magnitude of episodic memory disturbance in PSP is yet to be clarified. Objectives: To investigate how impaired is episodic memory in PSP compared to healthy controls and other neuropsychiatric disorders. Also, we sought to identify the brain correlates underlying these memory disturbances. Methods: We performed a systematic search on PubMed and Scopus, combining the terms "progressive supranuclear palsy" AND "memory". The search was limited to papers published in English, French, Portuguese or Spanish, with no chronological filters. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. Results: The initial search returned 464 results. After extraction of duplicates, 356 records were screened, leading to inclusion of 38 studies. Most studies found that PSP patients had lower scores on episodic memory compared to healthy controls. In addition, the majority of studies suggest that PSP does not differ from Parkinson's disease and from atypical parkinsonism in terms of episodic memory performance. The same is seen for PSP and frontotemporal dementia. Conversely, episodic memory impairment seems to be greater in typical Alzheimer's disease compared to PSP. Neuroimaging findings indicate that striatofrontal structures may be involved in PSP episodic memory dysfunction, while no associations with mesial structures (including hippocampi) were found. Conclusions: Episodic memory is impaired in PSP. Whether this amnesia refers to executive dysfunction is still controversial. More studies are warranted to clarify the neural basis of memory impairment in PSP.

Indexed as

episodic memoryparkinsonismprogressive supranuclear palsy

Identifiers

PMID35586534
PMCPMC9092732
OpenAlexW4221122366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.